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Objectives The aim of this study was to evaluate whether certain post-Maze left atrial (LA) contractile profiles may pose a
risk for ischemic stroke.
Background The mechanical contraction of the left atrium may be modified after the Maze procedure. Whether this imposes
a risk for stroke, even in the presence of sinus rhythm and after removal of the LA appendage, is not known.
Methods Clinical, surgery-related, and echocardiographic data from 150 patients who underwent radiofrequency and cryo-
ablation Maze procedures without the use of atrial incisions between 2004 and 2009 and were in sustained si-
nus rhythm were collected and analyzed. The occurrence of stroke was evaluated by reviewing clinical records.
All stroke events were adjudicated by a neurologist.
Results At a mean follow-up time of 24.5 months, 15 patients (10%) had experienced ischemic strokes. Forty-seven pa-
tients (31%) had no evidence of LA mechanical contraction at 3 months after surgery (baseline assessment) and
on follow-up echocardiography. Multivariate analysis showed that a lack of LA mechanical contraction at base-
line was associated with a 5-fold increase in the risk for stroke (p  0.02) during follow-up. Larger atria imposed
a significant risk as well; LA volume index 33 ml/m2 was associated with a 3-fold risk increase (p  0.03).
These effects were maintained regardless of the lack of mechanical valve implantation and anticoagulation
treatment.
Conclusions Absence of LA contraction and LA volume index 33 ml/m2 result in a significant increase in the risk for throm-
boembolic stroke after the Maze procedure for patients in sinus rhythm. (J Am Coll Cardiol 2011;58:1614–21)
© 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.05.051The surgical Maze procedure is a useful method for sinus
rhythm (SR) restoration in patients with atrial fibrillation
(AF) undergoing cardiac surgery for other indications. The
contemporary “modified” Cox Maze III procedure com-
prises multiple lines of radiofrequency and cryoablation in
the left atrium, aiming to isolate the pulmonary veins and
thus to create an electrical separation of the different parts of
the atrium (1,2). This method has an excellent success rate
for SR maintenance of up to 90% (3–5).
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relationships relevant to the contents of this paper to disclose. Drs. Buber and Luria
contributed equally to this work.Manuscript received November 24, 2010; revised manuscript received April 19,
2011, accepted May 15, 2011.Previous studies have shown that the left atrium might fail
to regain its full contractile capability after the Maze procedure
and the restoration of SR and thus may remain in a mechan-
ically nonfunctional state (6,7). Although the Maze procedure
has been shown to substantially reduce the risk for thrombo-
embolic events (8), it is not known whether this effect also
exists for patients with mechanically inactive left atria.
See page 1622
The aim of this study was therefore to determine whether
the lack of left atrial (LA) mechanical contraction (LAMC)
after the Maze procedure imposes an increased risk for the
occurrence of a thromboembolic stroke.
Methods
Study population. From February 2004 to November
2009, 236 patients underwent the Maze procedure at our
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October 4, 2011:1614–21 Stroke Occurrence After the Maze Procedureinstitution, using a combination of radiofrequency and
cryoablation lesions, as previously described (1). After sur-
gery, patients were followed up at our institutional AF and
cardiac surgery clinics, and all data were prospectively
obtained during their follow-up visits.
Patients were included in this study if: 1) normal SR was
documented beginning at the baseline 3-month post-
surgery visit and throughout follow-up (primary analysis) or
if normal SR was documented only at the baseline 3-month
visit, with follow-up censored upon the development of
non-SR (secondary analysis); 2) at least 1 detailed pre-
operative and 2 follow-up echocardiographic examinations
were performed; and 3) all demographic and clinical data
were available. Of the entire Maze-operated cohort, 158
patients (67%) had no evidence of AF or of other atrial
tachyarrhythmias during their follow-up. Eight patients (all
arriving from different countries to undergo the surgery)
were lost to follow-up, leaving 150 patients to be included in
this study.
Antiarrhythmic treatment was discontinued after surgery
and not renewed. In addition, 28 patients with normal SR
at the baseline visit who developed atrial arrhythmias during
follow-up (all within 6 months of follow-up) were included
in a secondary analysis (comprising a total of 178 patients
with normal SR at baseline). Anticoagulation treatment
with warfarin was discontinued 3 months after surgery and
was not renewed for patients who: 1) were not implanted
mechanical prosthetic valves; and 2) lacked other indications
for anticoagulation treatment.
For patients implanted with mechanical valves, treatment
with warfarin was continued for the entire follow-up period,
and for this study population, this was the only indication
for anticoagulation. All other study patients were treated
with either clopidogrel or aspirin.
Data collection. Baseline demographic and clinical data
were prospectively collected for all the patients. The
CHA2DS2-VASc score (consisting of congestive heart fail-
ure; hypertension; age [2 points if 75 years]; diabetes
mellitus; stroke, transient ischemic attack, or thromboem-
bolism [2 points]; vascular disease; age [65 to 74 years]; and
female sex category) was retrospectively calculated for each
patient (9). All patients underwent baseline electrocardio-
graphic and echocardiographic examinations before surgery.
Follow-up was conducted at our institution’s outpatient
clinics. A complete physical examination, review of hospi-
talization records after index surgery (if extant), 12-lead
electrocardiography, and 24-h Holter monitoring were per-
formed as described previously. Detailed echocardiographic
studies were performed at 3 and 12 months after surgery and
annually thereafter. All available clinical data from visits not
performed at our institution, including electrocardiography
and Holter monitoring, were obtained.
Echocardiographic methods. Echocardiography was per-
formed using commercially available systems (Philips iE33,
Philips Medical Systems, Bothell, Washington; Vivid 7,
GE Vingmed Ultrasound AS, Horten, Norway; Vivid I,GE, Tirat Carmel, Israel; or Sonos
7500, Hewlett-Packard, Andover,
Massachusetts), and echocardio-
grams were reviewed by an experi-
enced echocardiographer (R.K.).
LA measurements were performed
by two physicians (J.B. and R.K.)
unaware of each other’s readings,
according to the recommenda-
tions of the American Society of
Echocardiography for chamber
quantification (10). LA antero-
posterior diameter was measured
using 2-dimensional echocardi-
ography at the end of left ven-
tricular systole in the long-axis parasternal view. LA volume
was measured using Simpson’s method from the 4-chamber
apical view, indexed to body surface area (left atrial volume
index [LAVI]), and divided into quartiles at post-surgical
measurement of 21, 21.1 to 27, 27.1 to 32.9, and 33
ml/m2. Care was taken to exclude the pulmonary veins from
the LA tracing.
Transmitral peak velocity and the velocity-time integral
of the early (E) and late (A) filling waves were measured in
the apical 4-chamber view. The absence of an A wave on the
tracings was considered as the absence of mechanical atrial
contraction. All patients were in SR during the echocardio-
graphic examinations.
The study was approved by the Sheba Medical Center
Institutional Review Board.
End point evaluation. The end point of this study was
defined as the occurrence of an ischemic stroke suspected to
be of thromboembolic origin at any time during the
follow-up period. A stroke was defined as the sudden onset
of a focal neurologic deficit in a location consistent with the
territory of a major cerebral artery and lasting longer than
24 h. All patients who had strokes during the follow-up
period were hospitalized at our institution at the time of the
events. The adjudication of stroke events was based on the
diagnosis of an expert neurologist during the index hospital
stay. Brain computed tomography was performed, and
hemorrhagic stroke was excluded in all cases at the time of
arrival to the hospital. SR was confirmed for all patients at
the time of the occurrence of stroke by performing repeated
electrocardiography for the entire duration of the stroke-
related hospital stay.
Statistical analysis. The clinical characteristics of study
subjects stratified by the presence or absence of LAMC
and by the occurrence of stroke for patients without
LAMC were compared using chi-square tests for cate-
gorical variables and t tests or Mann-Whitney-Wilcoxon
tests for continuous variables. For time-to-event analyses,
the Kaplan-Meier method was used, and groups were
compared using log-rank statistics. Time 0 was defined as
the echocardiographic examination performed 3 months
Abbreviations
and Acronyms
AF  atrial fibrillation
CI  confidence interval
HR  hazard ratio
LA  left atrial
LAA  left atrial
appendage
LAMC  left atrial
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LAVI  left atrial volume
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Stroke Occurrence After the Maze Procedure October 4, 2011:1614–21therapy was discontinued for the patient group not
implanted with prosthetic valves. None of the strokes
occurred within this time period. The Cox proportional
hazards regression model was used to calculate the risk
for 3 pre-specified covariates of the study end point. The
3 covariates were assessed first separately using univariate
analysis, and only those with p values 0.10 were
ncluded in the final multivariate model. The pre-
pecified covariates included were lack of LA mechanical
unction, LAVI 33 ml/m2, and a CHA2DS2-VASc
score 2. LAVI was dichotomized at the upper quartile
(33 ml/m2) and compared with the 3 lower quartiles
(33 ml/m2) for our primary analysis. In a secondary
nalysis, event rates were also assessed by individual
AVI quartiles. Echocardiographic parameters used for
ll survival analyses were obtained at the baseline
-month echocardiographic assessment. Interaction-term
nalysis was used to assess the risk for stroke by atrial size
Figure 1 Sample Echocardiographic Examinations of 2 Patients
Examples of echocardiograms from a patient with (A) and without (B) left atrial An patients with absent LAMC by including an interac-
ion term for LAMC (yes or no) by LAVI (33 ml/m2)
n the multivariate model. A 2-sided p value  0.05 was
sed to denote statistical significance.
esults
f the 150 study patients, 47 (31%) had no evidence of
AMC at 3-month echocardiographic assessment after
ndex surgery (Fig. 1). Follow-up echocardiograms obtained
t 12 months and yearly thereafter showed consistent
ndings. Thus, none of the patients without LAMC at
aseline developed atrial contraction during follow-up, and
ll patients with LAMC at baseline continued to show
vidence of atrial contraction on follow-up echocardiogra-
hy. Baseline characteristics of the study patients stratified
y the presence of LAMC are presented in Table 1. Median
ollow-up periods were similar for the 2 groups (17 months
r the Modified Cox Maze III Procedure
, suggesting mechanically active and inactive atria, respectively.Afte
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October 4, 2011:1614–21 Stroke Occurrence After the Maze Procedurefor patients without LAMC and 19 months for those with
LAMC). Forty-one patients continued their anticoagula-
tion treatment during the entire follow-up period, all
because of prosthetic mechanical valve implantation. Of
these, 11 patients had no evident LAMC (constituting 23%
of this group), and 30 had intact LAMC (constituting 29%
of this group) (p  NS). None of the patients included in
the analysis was implanted with a permanent pacemaker.
Mechanical atrial activity and the occurrence of thrombo-
embolic stroke. Fifteen patients (10% of the entire study
sample) experienced ischemic strokes during follow-up,
while no hemorrhagic strokes occurred. Proof of left atrial
appendage (LAA) obliteration existed in 5 patients who had
strokes and was provided via transesophageal echocardiog-
raphy performed at a mean time of 32  8 h after
Baseline Characteristics ofthe Study P tients by LAMCTable 1 B seline Characteristics ofthe Study Patients by LAMC
Variable
No LAMC
(n  47)
LAMC
(n  103)
p
Value
Age at surgery (yrs) 62 12 63 11 0.88
Women 30 (64%) 41 (40%) 0.01
Body mass index (kg/m2) 27 5 28 5 0.67
Clinical variables
CHA2DS2-VASc score 2 31 (66%) 57 (55%) 0.22
Hypertension 29 (61%) 65 (64%) 0.81
Diabetes 12 (25%) 20 (19%) 0.41
Congestive heart failure 0 5 (5%) 0.09
Peripheral artery disease 9 (19%) 21 (20%) 0.83
Prior stroke 2 (5%) 4 (4%) 0.91
AF type 0.17
Paroxysmal 9 (19%) 22 (21%)
Persistent 16 (34%) 32 (31%)
Permanent 22 (47%) 48 (47%)
Echocardiographic parameters
Post-surgery LAVI (ml/m2) 29 13 28 10 0.40
Post-surgery LAVI 35 ml/m2 13 (27%) 19 (18%) 0.20
Post-surgery LA diameter (cm) 4.7 0.6 4.5 0.7 0.07
LAA removed 44 (93%) 99 (96%) 0.50
Post-surgery left ventricular ejection
fraction (%)
56 7 56 7 0.95
Post-surgery left ventricular ejection
fraction 35%
1 (2%) 3 (3%) 0.78
Surgery-associated parameters
CABG during surgery 9 (19%) 21 (20%) 0.86
Mechanical prosthetic valve implantation 11 (23%) 30 (29%) 0.85
Aortic valve operated 17 (36%) 22 (21%) 0.05
Mitral valve operated 36 (76%) 70 (68%) 0.28
Tricuspid valve operated 11 (23%) 19 (18%) 0.48
Maze only 0 6 (6%) 0.09
Time from surgery to last echocardiogram
(months)
12 (6–22) 12 (5–26) 0.81
Total follow-up (months) 17 (10–37) 19 (7–39) 0.61
Values mean  SD, n (%), or median (interquartile range). Percents may not total 100%, because
f rounding.
AF  atrial fibrillation; CABG  coronary artery bypass grafting; CHA2DS2-VASc  congestive
heart failure, hypertension, age 75 years, diabetes mellitus, stroke or transient ischemic attack,
vascular disease, age 65 to 74 years, and sex category (female); LA  left atrial; LAA  left atrial
ppendage; LAMC  left atrial mechanical contraction; LAVI  left atrial volume index.admission. All 5 patients belonged to the group of patientswith absent LAMC, and 3 of them belonged to the group
with LAVI 33 ml/m2 as well. In none of these patients
as flow beyond the line of LAA occlusion observed, and in
of them, the residual stump measured 1 cm, both
ndings suggesting adequate obliteration. There was no
vidence of thrombi in the left atria in these examinations,
et in 3 patients, severe swirling was observed.
Ten patients without LAMC (21%) had strokes, com-
ared to 5 (5%) with intact LAMC. Kaplan-Meier esti-
ates of event-free outcomes in the 2 groups are shown in
igure 2A. At 2-year follow-up, the cumulative probability
f survival without stroke was 43% in patients without
AMC, compared with 95% in those with intact LAMC
log-rank p  0.003 for the overall difference in event rates
during follow-up).
Three patients who had strokes were treated with anti-
coagulation at the time of their strokes (constituting 7% of
the entire anticoagulated group), of whom 2 had absent
LAMC, compared with 12 patients who had strokes and
were not receiving anticoagulation treatment (constituting
11% of the entire group not receiving anticoagulation; p 
NS). Of the 2 patients receiving anticoagulation without
LAMC, 1 had an international normalized ratio within the
therapeutic range (3.8), while the other had a considerably
lower international normalized ratio (1.2).
To evaluate the possible association between LAMC and
the occurrence of stroke in a manner that removed any
possible influence of both anticoagulation treatment and the
presence of a prosthetic mechanical valve (which alone may
be a source of embolization), we also examined the relation-
ship between LAMC and stroke in patients who did not
meet these criteria. A similar relationship existed within this
subgroup. The cumulative probability of survival without
stroke was 45% in patients without LAMC, compared with
95% in those with intact LAMC (log-rank p  0.01 for the
overall difference in event rates during follow-up) (Fig. 2B).
Multivariate Cox proportional hazards regression analysis
showed that the absence of LAMC was independently
associated with a nearly 5-fold (95% confidence interval
[CI]: 1.19 to 19; p 0.02) increase in the risk for stroke for
the entire study population and with a 4.1-fold (95% CI:
1.07 to 16.3; p  0.04) increase in risk for patients not on
anticoagulation treatment (Table 2).
LAVI and the occurrence of thromboembolic stroke. Of
the entire study population, 35 patients had LAVI 33
ml/m2, of whom 8 (23%) had ischemic strokes. During
follow-up, the cumulative probability of no stroke event was
55% in patients with LAVI 33 ml/m2, compared with
4% in those with LAVI 33 ml/m2 (log-rank, p  0.01)
Fig. 2C). This effect was more moderate for the subpop-
lation of patients not receiving anticoagulation therapy
log-rank p  0.07; data not shown). Multivariate Cox
roportional hazards regression analysis showed that LAVI
33 ml/m2 was associated with 3-fold risk increase for
stroke in the entire study population (95% CI: 1.10 to 9.48;
p 0.03). To confirm the relationship between higher atrial
L1618 Buber et al. JACC Vol. 58, No. 15, 2011
Stroke Occurrence After the Maze Procedure October 4, 2011:1614–21Figure 2 Stroke Event Rates
Kaplan-Meier estimates of the probability of survival free of stroke by left atrial
mechanical contraction (LAMC) (A), by LAMC in patients not on anticoagulation
therapy (B), and by left atrial (LA) volume index greater or lower than 33
ml/m2. “Baseline echo” refers to the echocardiographic study performed 3
months after index surgery.volume and the risk for thromboembolic stroke, we per-
formed a separate multivariate model, incorporating LAVI
as a continuous variable. In this separate model, higher
LAVI was similarly independently associated with an in-
creased risk for stroke (hazard ratio [HR]: 1.03; 95% CI:
1.01 to 1.07; p 0.02; data not shown). A similar trend, but
without statistical significance, also existed for patients not
receiving anticoagulation therapy with LAVI 33 ml/m2
(HR: 3.33; 95% CI: 0.93 to 11.9; p  0.06) (Table 2).
Risk for stroke by LAVI in patients without LAMC. In
the total study population, the only parameters that were
significantly different between those who did and did not
develop strokes were the presence or absence of LAMC and
LAVI 33 ml/m2. The CHA2DS2-VASc score was not
found to be associated with an increased risk for stroke in
the entire cohort. In Table 3, a comparison of selected
parameters among the group of patients without LAMC
stratified by the occurrence of stroke is shown. The only
parameter statistically different between the groups was
LAVI 33 ml/m2. Interaction-term analysis showed that
the risk for stroke in patients without LAMC was similar
between those with LAVI 33 ml/m2 and those with
AVI 33 ml/m2 (p for the difference  0.75). However,
the lack of a statistically significant interaction in the effect
of LAVI on the risk for stroke in patients without LAMC
may have been due to the limited number of end point
events in the present analysis (n  15).
Multivariate Analysis of the Effects of LAMC andLAVI >33 ml/m2 on the Risk or Str ke in theSt dy Population*
Table 2
Multivariat Analysis of th Effects of LAMC and
LAVI >33 ml/m2 on the Risk for Stroke in the
Study Population*
Study Population HR 95% CI p Value
Entire study population (n  150)
Absent LAMC 4.76 1.19–19.0 0.02
LAVI 33 ml/m2 3.23 1.10–9.48 0.03
Patients not on anticoagulation therapy (n  107)
Absent LAMC 4.18 1.07–16.3 0.04
LAVI 33 ml/m2 3.33 0.93–11.9 0.06
*Further adjusted for CHA2DS2-VASc score 2.
CI  confidence interval; HR  hazard ratio; other abbreviations as in Table 1.
Selected Clinical Parameters for PatientsWithout LAMC by the Occu rence of StrokeTable 3 Selected Clinical Parameter for PatientsWithout LAMC by the Occurrence of Stroke
Variable
Stroke
(n  10)
No Stroke
(n  37)
p
Value
Age at surgery (yrs) 59 15 63 11 0.33
Women 6 (60%) 24 (64%) 0.77
Post-surgery LAVI 33 ml/m2 7 (70%) 6 (16%) 0.001
CHA2DS2-VASc score 2 6 (60%) 25 (65%) 0.65
Mechanical prosthetic valve implantation at
surgery*
2 (20%) 9 (24%) 0.77
Post-surgery left ventricular ejection fraction (%) 53 8 56 7 0.21
Time from surgery to last echocardiogram
(months)
18.5 15 16 15 0.67
Total follow up (months) 18 (5–30) 20 (6–29) 0.59
Values are mean  SD, n (%), or median (interquartile range). Percents may not total 100%,
because of rounding. *All prosthetic valves were implanted in the aortic position.
Abbreviations as in Table 1.
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October 4, 2011:1614–21 Stroke Occurrence After the Maze ProcedureRisk for stroke in patients who developed atrial arrhythmias
before and during follow-up. Because of the very high rate of
post-Maze stroke events in the study subjects, we also
evaluated stroke incidence in the 78 patients who developed
episodes of AF or other atrial arrhythmias and were ex-
cluded from the analysis to determine whether these pa-
tients sustained a similar risk for stroke. Follow-up data
were available for 100% of these patients, of whom 5 (6%)
had strokes. However, information regarding the interna-
tional normalized ratio and the mechanism and adjudication
of the stroke event was available for only 3 patients. For the
majority of these patients, atrial arrhythmias were desig-
nated as permanent, so evaluation of the LAMC profile on
echocardiography was not possible, because of a lack of
effective LA contraction secondary to the presence of these
arrhythmias. Thus, stroke incidence in the post-Maze atrial
arrhythmia group was similar to that in the group with
intact LAMC and significantly lower than that in the group
with absent LAMC (p  0.001 for between-group differ-
ence; data not shown). Of the aforementioned 78 patients,
28 had normal SR at the baseline 3-month visit but
developed atrial arrhythmias during follow-up. Within this
subgroup, 27 patients (96%) had echocardiographic evi-
dence of intact LAMC at baseline and throughout follow-
up, and 1 patient without evidence of LAMC at baseline
experienced a stroke during follow-up (after the develop-
ment of AF). When this patient subgroup was added to the
primary cohort, a secondary multivariate analysis (which
included all 178 patients who had normal SR at the
baseline, with follow-up censored upon the development of
AF) showed consistent results: a lack of LAMC was
associated with a nearly significant 4-fold increase in the risk
for stroke (HR: 3.83; 95% CI: 1.21 to 12.10), and LAVI
33 ml/m2 was associated with a significant 2.5-fold risk
increase (HR: 2.48; 95% CI: 1.01 to 4.90).
Discussion
Main findings. In this single-center study, we examined
for the first time the risk for ischemic stroke in 150 patients
who underwent surgery that included the modified Cox
Maze III procedure and subsequently remained in SR. Our
main findings are that: 1) for one-third of the patients with
sustained SR, no mechanical activity of the left atrium was
observed during 2 years of follow-up; 2) a lack of LAMC
was found to be independently associated with a 5-fold
increase in the risk for stroke; 3) LAVI 33 ml/m2 was
ound to be independently associated with a 3-fold increase
n the risk for stroke; and 4) these effects existed regardless
f the absence of a mechanical prosthetic valve and antico-
gulation treatment.
revious data on LA performance after the Maze procedure.
everal previous studies have addressed the issue of post-
aze LA function and filling capacities. Feinberg et al. (7)
ound that only 60% of patients who underwent the Maze
rocedure had evidence of LA contraction after a meanollow-up period of 8  7 months and subsequently
onfirmed this observation by additional echocardiographic
echniques (11). Yashima et al. (6) reported on the early and
ate echocardiographic follow-up of 35 patients with chronic
F who underwent the Maze procedure at the time of other
urgery. On early post-operative echocardiography, 5 pa-
ients exhibited no evidence of LA contraction, which later
mproved to some extent but was still depressed at the end
f the follow-up period. Our study is consistent with these
ndings, showing that for a significant percent of patients
ndergoing the Maze procedure, LA “electromechanical
issociation” may occur. Apparently, the less extensive
esions associated with the modified Cox Maze III proce-
ure, as well as the use of radiofrequency and cryoablation
echniques, do not protect against this LA standstill phe-
omenon. It is likely that this condition undergoes sponta-
eous resolution in some patients, while in others, it may be
ong lasting or even become sustained.
hromboembolic risk. Two important findings of our
tudy should be further emphasized. First, although the
AA is considered to be the main source of emboli during
F, its removal during surgery (as performed in 95% of our
ohort) was not protective against thromboembolic compli-
ations. The underlying mechanism might be the formation
f a thrombus in the noncontractile LA space or in the
ppendage stump due to its incomplete removal. This
henomenon is somewhat similar to that occurring at the
ime of LA stunning after cardioversion of AF lasting
onger than 48 h (12–14). Second, no relation was found in
his study between the recently established CHA2DS2-
VASc score for stroke prediction and the risk for events in
patients without LAMC (Table 3). This finding suggests
that LA mechanical standstill is an independent and pow-
erful risk factor for a thromboembolic stroke, which should
be accounted for when considering anticoagulation treat-
ment for post-Maze patients.
As observed in previous studies (6,7), patients who
underwent the Maze procedure may also obtain a decreased,
rather than absent, LA contractile profile. This group of
patients was identified among our study subjects as well but
was not evaluated separately for the occurrence of stroke.
Further studies concerning outcomes in this subpopulation
are certainly required.
The modified Cox Maze III procedure is currently
considered a safe and effective procedure for the mainte-
nance of SR, and its performance was found to obtain
beneficiary effects in prior studies (15) as well as in our study
population. These effects, although not addressed in the
present analysis, are of considerable importance and include
an increase in the left ventricular ejection fraction, freedom
from the need for antiarrhythmic drugs, freedom from
palpitations, and a decrease in New York Heart Association
functional class. Nevertheless, on the basis of the results of
the present study, absence of LA contraction and an
enlarged left atrium (defined as LAVI 33 ml/m2) on
consecutive post-operative echocardiograms is associated
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Stroke Occurrence After the Maze Procedure October 4, 2011:1614–21with an increased risk for subsequent cerebral thromboem-
bolic events. The absence of LAMC after the Cox Maze
procedure should alert physicians to the possible risk for
future strokes, and further studies are indicated to examine
the need for chronic anticoagulation treatment for patients
with LA mechanical standstill.
Study limitations. The data for this study were retrospec-
ively analyzed, and groups were not randomized into
nticoagulation treatment arms to determine the preventive
ffect of anticoagulation on patients without LAMC. Inter-
ational normalized ratios were not available for some of the
tudy patients, so we were unable to evaluate whether a
ossible relationship existed between event occurrence and
he adequacy of anticoagulation. To overcome this limita-
ion, data were provided on the subgroup of patients who
ere not on anticoagulation treatment.
Asymptomatic AF could have occurred, because AF
ecognition was based on symptoms and periodic Holter
xaminations. It is possible therefore that our results were
verestimated, because asymptomatic paroxysmal AF may
till have been present at the time of the stroke but not
ppeared on the later electrocardiographic tracings obtained
uring the hospital stay.
The contribution of a decreased, rather than absent, LA
ontractile profile to the occurrence of stroke was not
ssessed in the present study, and this situation might by
tself possess a risk for the occurrence of such events.
The majority of our study patients did not undergo
ransesophageal echocardiography to ascertain complete
AA obliteration or to directly visualize LA thrombus at
he time of the stroke event. However, adequate LAA
bliteration was demonstrated for all 5 patients who did
ndergo transesophageal echocardiography during stroke-
elated hospital stay. In addition, currently available data
ndicate that successful LAA obliteration rates tend to
ignificantly increase along with increased surgeon experi-
nce and may be as high as 90% (16). In our study patients,
ll but 5 LAA obliterations were carried out by a single
urgeon, suggesting a very high level of skill. In addition,
ontradictory results have been reported from a single
andomized controlled trial (consisting of 77 patients) (17)
nd several observational studies (18,19) that aimed to
valuate the actual protective effect of complete LAA
bliteration from subsequent thromboembolic stroke events
or patients in SR. We therefore believe that the lack of
omplete data regarding the obliteration of the LAA in this
tudy should not be considered an obstacle in the interpre-
ation and future implications of its results.
Although the present study represents a large population
f patients who were prospectively followed up after Maze
rocedures, the number of end point events in the study was
imited (n 15). Accordingly, the multivariate models were
djusted for only 2 pre-specified predictors, resulting in only
odest overfitting. As mentioned previously, the lack of a
tatistically significant interaction in the effect of LAVI on
he risk for stroke in patients without LAMC may bebecause the study was not adequately powered to detect
interaction effects.
Conclusions
For patients who undergo the modified Cox Maze III
procedure, the absence of LAMC is common and is
independently associated with an increased risk for throm-
boembolic stroke. This risk is sustained regardless of the
presence of stable SR. In addition, LAVI 33 ml/m2 is
independently associated with increased risk for thrombo-
embolic stroke. We therefore assume that for patients who
undergo Maze procedures, routine echocardiographic
follow-up examinations should be performed, with an em-
phasis on recording the contractility profile and volume
measurement of the left atrium. Anticoagulant treatment
should be strongly considered for patients with absent
LAMC and with LAVI 33 ml/m2.
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